All In Biotech

Drug Trial Radar · NCT06248619

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

A Phase 3, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Teprotumumab in Participants With Moderate-to-Severe Active Thyroid Eye Disease

Last checked: Nov 20, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

89

Actual

Start

Jul 5, 2024

Primary completion

Dec 23, 2025

Study completion Nov 13, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Feb 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study consists of a randomized double-masked, placebo-controlled, parallel-group, multicenter trial with an optional open-label treatment period for proptosis non-responders who complete the Double-masked Treatment Period.

Conditions

  • Thyroid Eye Disease

Interventions

  • TeprotumumabBiological

    SC injection

  • PlaceboOther

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proptosis responder rate (percentage of participants with a ≥ 2-mm reduction from baseline in proptosis in the study eye without deterioration [≥ 2-mm increase] of proptosis in the fellow eye).Time frame: Week 24

Locations

38 sites in 11 countries. Site status is shown where the registry gives one.

  • Catalina Eye Care - NVISION - PPDS

    Tucson, Arizona

  • Advanced Quality Medical Research

    Orland Park, Illinois

  • W Kellogg Eye Center

    Ann Arbor, Michigan

  • Las Vegas Endocrinology

    Henderson, Nevada

  • The Center for Eye and Facial Plastic Surgery

    Somerset, New Jersey

  • Casey Eye Institute -515 SW Campus Dr

    Portland, Oregon

  • Scheie Eye Institute

    Philadelphia, Pennsylvania

  • University of Tennessee Health Science Center - 848 Adams Ave

    Memphis, Tennessee

  • Baylor College of Medicine-1977 Butler Blvd

    Houston, Texas

  • University of Washington Eye Institute

    Seattle, Washington

  • West Virginia University Eye Institute

    Morgantown, West Virginia

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • Organización Médica de Investigación

    Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

  • Centro Medico Grupo Laser Vision

    Rosario, Santa Fe Province, Argentina

  • Sydney Eye Hospital

    Sydney, New South Wales, Australia

  • Queensland Eye Institute

    Wooloongabba, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaie, South Australia, Australia

  • Centre For Eye Research Australia Ltd

    East Melbourne, Victoria, Australia

  • CHU de Quebec-Universite Laval CUO Recherche Clinique Hopital du St-Sacrement

    Québec, Canada

  • Vancouver Coastal Health Research Institute (VCHRI) - 2550 Willow St

    Vancouver, British Columbia, Canada

  • McGill University Health Centre Research Institute

    Montreal, Quebec, Canada

  • AP-HM-Hôpital de La Conception

    Marseille, Bouches-du-Rhône, France

  • Universitätsklinikum Essen

    Essen, North Rhine-Westphalia, Germany

  • Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello

    Pisa, Italy

  • Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara

    Pisa, Italy

  • Azienda Ospedaliera Universitaria Federico II

    Naples, Campania, Italy

  • Hayashi Eye Hospital

    Fukuoka, Hukuoka, Japan

  • Kozawa Eye hospital and Diabetes Center

    Mito, Ibaraki, Japan

  • Ishikawa Prefectural Central Hospital

    Kanazawa, Ishikawa-ken, Japan

  • University of Miyazaki Hospital

    Miyazaki, Miyazaki, Japan

  • Gokeikai Osaka Kaisei Hospital

    Osaka-Shi Yodogawa-Ku, Ôsaka, Japan

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain

  • Hospital Universitario Virgen Macarena

    Seville, Spain

  • Hospital Universitari i Politecnic La Fe de Valencia-Avda de Fernando Abril Martorell 106

    Valencia, Spain

  • Changhua Christian Hospital

    Changhua County, Taiwan

  • Chung Shan Medical University Hospital

    Taichung, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Moorfields Eye Hospital - PPDS

    London, Middlesex, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.